Prostate Cancer Risk Factors
Reports from British Columbia Cancer Agency advance knowledge in prostate cancer risk factors
Published in Medical Device Business Week, May 28th, 2008
A report, 'Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy,' is newly published data in Cancer. "In men with prostate cancer, pretreatment prostate-specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes after radiotherapy (RT), with or without androgen-deprivation therapy (ADT), is less certain," scientists writing in the journal Cancer report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Adverse Drug Reactions
New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery - Agilent Technologies Inc.
TRADE NEWS: Agilent Technologies Introduces LC Workflow Enhancements at HPLC 2008 Symposium - AirStrip Technologies
AirStrip Technologies Announces Memorial Hermann Partnership - AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Added to NASDAQ Biotech Index - American Association of Clinical Endocrinologists
AACE Calls for New Standards for Safer Insulin Pump Use - American Society of Plastic Surgeons
A Range of Cosmetic Medicine Procedures for Any Age - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
